Home > Course catalogue > Medication Therapy Management in Chronic Kidney Disease
Medication Management in Chronic Kidney Disease Online Course
Did you know that one in eight Americans has Chronic Kidney Disease (CKD)?
Yes, its true, and CKD leads to many complications including cardiovascular disease, anemia and bone and mineral metabolism disorders. Currently, CKD is under-detected and management is suboptimal leading to significant morbidity, mortality and health care costs.
Reasons for suboptimal care are multifactorial, but stem in part from lack of nephrology-trained practitioners and undefined roles for various practitioners in the care of these patients.
Pharmacists frequently interface with Chronic Kidney Disease (CKD) patients because these patients are prescribed a multitude of medications. On average, a patient with end-stage kidney disease (ESKD) is prescribed 10-12 medications. Kidney disease often requires patient-specific medication dosing because the kidney plays an important role in drug disposition. The effects of various dialysis techniques and dialysis membranes on drug clearance need to be considered.
ESKD patients on dialysis are entitled to Medicare coverage. Many patients with CKD not on dialysis are over 65 years of age and also receive Medicare benefits. Thus, a good portion of CKD patients are qualified to receive Medicare Part D benefits. Medicare Part D has opened up opportunities for pharmacists to provide and be reimbursed for medication therapy management services in patients receiving Medicare benefits.
Return
to: College of Pharmacy : U of M Home
